NovantroneActive Ingredient(s): Mitoxantrone
FDA Approved: * December 23, 1987
Pharm Company: * SERONO INC
Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse. The combination of mitoxantrone and prednisone is app... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.